
389: Hims' Super Bowl fallout, and the FDA reverses course
The Readout Loud
00:00
Interpreting Compass' MADRS results
Elaine explains endpoints, response definitions, and why modest effect sizes still matter in depression trials.
Play episode from 06:53
Transcript


